{"disease":{"id":"persistent-cervical-carcinoma","name":"persistent cervical carcinoma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05290935","title":"Immunotherapy for Recurrent Cervical Cancer Refractory to Platinum-based Chemotherapy: Multi-Center Trial","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":122,"lead_sponsor_name":"Lei Li","has_results":false},{"nct_id":"NCT05310383","title":"Tislelizumab and Radiotherapy for Recurrent Cervical Cancer","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":58,"lead_sponsor_name":"Lei Li","has_results":false},{"nct_id":"NCT04188847","title":"First-line Chemotherapy for Recurrent Cervical Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":37,"lead_sponsor_name":"Lei Li","has_results":false},{"nct_id":"NCT04188860","title":"Immunotherapy for Recurrent Cervical Cancer Refractory to Platinum-based Chemotherapy","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":34,"lead_sponsor_name":"Lei Li","has_results":false},{"nct_id":"NCT01267253","title":"Brivanib Alaninate in Treating Patients With Persistent or Recurrent Cervical Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":31,"lead_sponsor_name":"Gynecologic Oncology Group","has_results":true},{"nct_id":"NCT05310331","title":"Donafenib for Recurrent Cervical Cancer","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"Lei Li","has_results":false},{"nct_id":"NCT05310305","title":"PD-1 Antibody and Radiotherapy for Recurrent Cervical Cancer","phase":"","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"Lei Li","has_results":false}],"total":7},"guidelines":[],"source":"Drug Landscape verified database"}